To our knowledge, this study was first to elucidate the roles and molecular basis of TUG1 in MM tumorigenesis, providing some potential biomarkers for MM diagnosis and prognosis, and possible targets for the treatment of MM. This evidence concerns the gene TUG1 and Miyoshi myopathy.